BlackRock, Inc. 13D and 13G filings for Turning Point Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | Turning Point Therapeutics, Inc. TPTX |
BlackRock Inc. BLK |
3,783,325 7.600% |
625,938 (+19.82%) |
Filing |
| 2021-02-01 08:23 am Purchase |
2020-12-31 | 13G | Turning Point Therapeutics, Inc. TPTX |
BlackRock Inc. BLK |
3,157,387 6.600% |
1,026,556 (+48.18%) |
Filing |